Ookura, M., Fujii, T., Yagi, H., Ogawa, T., Kishi, S., Hosono, N., . . . Yoshida, A. (2017). YM155 exerts potent cytotoxic activity against quiescent (G(0)/G(1)) multiple myeloma and bortezomib resistant cells via inhibition of survivin and Mcl-1. Oncotarget.
Chicago Style CitationOokura, Miyuki, et al. "YM155 Exerts Potent Cytotoxic Activity against Quiescent (G(0)/G(1)) Multiple Myeloma and Bortezomib Resistant Cells Via Inhibition of Survivin and Mcl-1." Oncotarget 2017.
MLA CitationOokura, Miyuki, et al. "YM155 Exerts Potent Cytotoxic Activity against Quiescent (G(0)/G(1)) Multiple Myeloma and Bortezomib Resistant Cells Via Inhibition of Survivin and Mcl-1." Oncotarget 2017.
Warning: These citations may not always be 100% accurate.